Deoxycholic acid-modified polyethylenimine based nanocarriers for RAGE siRNA therapy in acute myocardial infarction

다국어 초록 (Multilingual Abstract)

The activation of receptor for advanced glycation end products (RAGE) signaling is mainly associated with myocardial ischemia/reperfusion injury. Thus the blockade of RAGE-ligands axis can be considered as a potential therapeutic strategy to protect myocardial infarction after ischemia/reperfusion injury. Herein, we strengthened the cardioprotective effect with combinatorial treatment of soluble RAGE (sRAGE) and RAGE siRNA (siRAGE) causing more effective suppression of RAGEmediated signaling transduction. For pharmacological blockadeofRAGE,sRAGE,theextracellularligandbinding domain of RAGE, acts as a pharmacological ligand decoy and inhibits the interaction between RAGE and its ligands. For genetic deletion of RAGE, siRAGE suppresses the expression of RAGE by participating in RNA interference mechanism. Therefore, we combined these two RAGE blockade/deletionstrategiesand investigated thetherapeutic effects on rat ischemic and reperfused myocardium. According to our results, based on RAGE expression level analysis and infarct size/fibrosis measurement, co-treatment of sRAGE and siRAGE exhibited synergic cardioprotective effects; thus the newly designed regimen can be considered as a promising candidate for the treatment of myocardial infarction.

참고문헌 (Reference)

1 Yan, S.F., "The receptor for advanced glycation endproducts (RAGE) and cardiovascular disease" 11 : e9-, 2009

2 Lee, D., "The effect of soluble RAGE on inhibition of angiotensin II-mediated atherosclerosis in apolipoprotein E deficient Mice" 8 : e69669-, 2013

3 Muhammad, S., "The HMGB1 receptor RAGE mediates ischemic brain damage" 28 : 12023-12031, 2008

4 Xia, J.-R., "Specific siRNA targeting the receptor for advanced glycation end products inhibits experimental hepatic fibrosis in rats" 9 : 638-661, 2008

5 Santilli, F, "Soluble forms of RAGE in human diseases : clinical and therapeutical implications" 16 : 940-952, 2009

6 Godbey, W.T., "Size matters : Molecular weight affects the efficiency of poly(ethylenimine)as a gene delivery vehicle" 45 : 268-275, 1999

7 Bucciarelli, L.G., "Receptor for advanced-glycation end products : key modulator of myocardial ischemic injury" 113 : 1226-1234, 2006

8 Aleshin, A., "RAGE modulates myocardial injury consequent to LAD infarction via impact on JNK and STAT signaling in a murine model" 294 : H1823-H1832, 2008

9 Hofmann, M.A., "RAGE mediates a novel proinflammatory axis : a central cell surface receptor for s100/ calgranulin polypeptides" 97 : 889-901, 1999

10 Bucciarelli, L.G., "RAGE and modulation of ischemic injury in the diabetic myocardium" 57 : 1941-1951, 2008

11 Lu, Q.L., "Non-viral gene delivery in skeletal muscle : a protein factory" 10 : 131-142, 2003

12 Abu-Amara, M., "Liver ischemia/reperfusion injury : Processes in inflammatory networks—A review" 16 : 1016-1032, 2010

13 Kim, H., "Hypoxia-inducible vascular endothelial growth factor gene therapy using the oxygen-dependent degradation domain in myocardial ischemia" 27 : 2075-2084, 2010

14 Andrassy, M., "Highmobility group box-1 in ischemia-reperfusion injury of the heart" 117 : 3216-3226, 2008

15 Ruponen, M., "Extracellular glycosaminoglycans modify cellular trafficking of lipoplexes and polyplexes" 276 : 33875-33880, 2001

16 Chae, S.Y., "Energy-independent intracellular gene delivery mediated by polymeric biomimetics of cell-penetrating peptides" 11 : 1169-1174, 2011

17 Meloche, J., "Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology" 2 : e005157-, 2013

18 Zeng, S., "Blockade of receptor for advanced glycation end product(RAGE)attenuates ischemia and reperfusion injury to the liver in mice" 39 : 422-432, 2004

19 Kim, D., "Anti-apoptotic cardioprotective effects of SHP-1 gene silencing against ischemiareperfusion injury : use of deoxycholic acid-modified low molecular weight polyethyleneimine as a cardiac siRNA-carrier" 168 : 125-134, 2013

20 Ramasamy, R, "Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation" 15 : 16R-28R, 2005

21 Xu, Y., "Advanced glycation end product(AGE)-receptor for AGE(RAGE)signaling and upregulation of Egr-1 in hypoxic macrophages" 285 : 23233-23240, 2010

22 Orlova, V.V., "A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin" 26 : 1129-1139, 2007